Fundamental Analysis
26 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -126.5% | -147.7% | 1 / 3 | -53.6% | -1.16 pp | -41.94 pp | -2.9% | 0.15 | — | 7,9 | −53,6% | −4,2 | −124,8% | — | 5.19 | — |
| Pts | 0 | 0 | 4 | 0 | 4 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 1.500 (close price on 2026-10-19)EPS (TTM): −371,8
Financial charts
1.Revenue & growth
VND bn7,93Q2/26
1.Revenue & growth
VND bn7,93Q2/26
2.Profit & growth
VND bn-4,15Q2/26
3.Profit mix (Penman)
VND bn-11,4Q2/26
4.Margins & cost structure
%14.8%Q2/26
5.Returns & cash cycle
% · days-1.5%Q2/26
6.Earnings quality & cash
VND bn12,6Q2/26
7.Asset structure
VND bn467Q2/26
8.Funding & debt health
VND bn · times467Q2/26
9.Revenue backlog
VND bn2,06Q2/26
10.Valuation
times · %-3,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-140Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-350%
averaged over 1 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26